pentylenetetrazole has been researched along with Idiopathic Parkinson Disease in 2 studies
Pentylenetetrazole: A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility.
pentetrazol : An organic heterobicyclic compound that is 1H-tetrazole in which the hydrogens at positions 1 and 5 are replaced by a pentane-1,5-diyl group. A central and respiratory stimulant, it was formerly used for the treatment of cough and other respiratory tract disorders, cardiovascular disorders including hypotension, and pruritis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| SCHWAB, RS | 1 |
| ENGLAND, AC | 1 |
| Avakian, RM | 1 |
| Dutov, AA | 1 |
| Parkhomenko, VM | 1 |
2 other studies available for pentylenetetrazole and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Problems in the treatment of Parkinsonism by analeptics.
Topics: Amphetamine; Amphetamines; Apomorphine; Central Nervous System Stimulants; Humans; Parkinson Disease | 1956 |
[Preconvulsive state and hyperfunction of the striatum (clinico-experimental findings)].
Topics: Adolescent; Adult; Aged; Animals; Apomorphine; Convulsants; Corpus Striatum; Electroencephalography; | 1976 |